Next Article in Journal
Novel Developments in Angiogenesis Cancer Therapy
Previous Article in Journal
The Emerging Role of IG-IMRT for Palliative Radiotherapy: A Single-Institution Experience
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on as a courtesy and upon agreement with Multimed Inc..
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:

Exosomes in Tumour Immunity

Section of Clinical Oncology and Palliative Medicine, Department of Pharmacology, Oncology and Radiology, School of Medicine, Cardiff University, Velindre Cancer Centre, Whitchurch, Cardiff, Wales CF14 2TL, UK
Author to whom correspondence should be addressed.
Curr. Oncol. 2009, 16(3), 46-49;
Submission received: 5 February 2009 / Revised: 6 March 2009 / Accepted: 7 April 2009 / Published: 1 May 2009


Note: In lieu of an abstract, this is an excerpt from the first page.

Exosomes are nanometre-size vesicles manufactured within late multi-vesicular endosomes and actively secreted into the extracellular environment [...]

Share and Cite

MDPI and ACS Style

Clayton, A.; Mason, M.D. Exosomes in Tumour Immunity. Curr. Oncol. 2009, 16, 46-49.

AMA Style

Clayton A, Mason MD. Exosomes in Tumour Immunity. Current Oncology. 2009; 16(3):46-49.

Chicago/Turabian Style

Clayton, A., and M. D. Mason. 2009. "Exosomes in Tumour Immunity" Current Oncology 16, no. 3: 46-49.

Article Metrics

Back to TopTop